Lotus Pharma 美時製藥

Founded in 1966, Lotus now is the largest pharmaceutical company in Taiwan focusing on high-value generic products covering CNS, CVS, oncology, women health, and anti-obesity drugs in tablets & hard/softgel capsule for global markets.
Lotus has more than 100 strategically selected pharmaceutical projects in development and registrations across Asia and the US, and has more than 250 products in the market. Lotus invests in diversifying best portfolio consisting high-barrier oncology, complex generics and 505(b)2 via internal R&D investment and licensing-in partnership, and also strengthens its portfolio competitiveness by adding biosimilar products with support from strategic partners.

美時化學製藥成立於1966年，專注於高價位的學名藥產品，其中涵蓋中樞神經系統、心血管疾病、癌症用藥、女性保健、體重管理、疼痛緩解及呼吸系統等治療領域，並以錠劑、膠囊及軟膠囊等劑型的研發與製造為主，希冀提升台灣的醫療產業。
我們不僅持續強化研發能力，同時藉由外部夥伴的結盟合作加強營運效率及彈性，優化公司整體競爭優勢。此外，借助艾威群集團的全球網絡與銷售平台，美時製藥不僅持續深耕原有的亞洲市場，包含韓國、台灣、中國、印度，並外銷至日本與東南亞國家，更成功拓展版圖至美國與中東歐。